High Potency APIs Market Growth & Share | Report 2022, 2028

report image

High Potency APIs Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type (Generic and Innovative), Type of Synthesis (Synthetic and Biotech), Manufacturer (In-House and Outsourced), and Therapeutic Application (Oncology, Hormonal Imbalance, Glaucoma, and Others)

Report Code: TIPRE00003533 | No. of Pages: No. of Pages150 | Category: Pharmaceuticals | Status: Prebook

The high potency APIs market is expected to grow from US$ 22.74 billion in 2021 to US$ 42.65 billion by 2028; it is expected to grow at a CAGR of 9.4% from 2022 to 2028.

The high potency active pharmaceutical ingredients are highly effective even in small amount. The  HPAPIs target specific abnormal cells and destroys them. Hence, they are used in the drugs prescribed for the treatment of chronic diseases.  The importance of API manufacturers in the pharmaceutical industry is changing as a result of new customer demands and increasing pressures from global competitors, which is offering lucrative opportunities for the market. With regard to entrance obstacles, regulatory constraints, large investments, and knowledge-related to APIs and HPAPI development, manufacturers with different experiences are making significant investments in HPAPI capabilities.


The growth of the high potency APIs market is majorly attributed to the growing demand for antibody-drug conjugates, rising prevalence of cancer, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine. Moreover, the growing adoption of HPAPI in different applications and the high growth in cancer therapeutics would supplement market growth during the forecast period. However, dearth of skilled professionals is hampering the growth of the market.


The “Global High Potency APIs market Forecast to 2028” report aims to provide an overview of the high potency APIs ( market with detailed market segmentation based on type, type of synthesis, manufacturer, and therapeutic application. The report provides key market statistics based on the performances of the leading players. It also offers key trends and opportunities in the market.

Strategic Insights

Report Coverage - High Potency APIs Market
Report CoverageDetails
Market Size Value inUS$ 22.74 billion in 2021
Market Size Value byUS$ 42.65 billion by 2028
Growth rateCAGR of 9.4% from 2022 to 2028
Forecast Period2022-2028
Base Year2021
No. of Pages150
Historical data availableYes
Segments coveredType, Type of Synthesis, Manufacturer, and Therapeutic Application
Regional scopeNorth America; Europe; Asia Pacific; Latin America; MEA
Country scopeUS, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available


The global high potency APIs market is segmented on the basis of type, type of synthesis, manufacturer, and therapeutic application. Based on type, the market is bifurcated into generic and innovative. Based on type of synthesis, the market is segmented into synthetic and biotech. Based on manufacturer, the high potency APIs ( market Is segmented into in-house and outsourced. By therapeutic application, the market is segmented into oncology, hormonal imbalance, glaucoma, and others.


The global high potency APIs market is segmented into five major regions—North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The report covers analysis and forecast of 18 countries across the world along with trends and opportunities prevailing in the region. From the regional perspective, North America dominated the market with ~35% share in 2021. The market growth in the region is majorly attributed to the presence of prominent manufacturers and advanced technological infrastructure. Additionally, the high prevalence of chronic diseases, such as cancers, in the region is driving the market growth. The below figure shows the revenue growth trend in the global high potency APIs ( market:

High Potency APIs Market

Get more information on this report :

Source: The Insight Partners Analysis

The report analyzes factors, such as drivers, restraints, opportunities, and future trends, which impact the high potency APIs market. It also provides an exhaustive Porter's five forces analysis of the factors influencing the market.


The high-potency APIs/HPAPI market suffered during the COVID-19 pandemic due to disrupted supply chain. China and India are the two countries where most API is produced. In 2020, according to the Germany Trade & Invest (GTAI), around 60% of the world's APIs, particularly high-potency APIs, are made in China or India, and 18% of the generic medicine production market worldwide is accounted for by India alone. The majority of this produced medicines are exported to other nations. Also, 70% of India's generics industry's APIs, particularly high-potency APIs, are produced in China, a significant manufacturing hub. These countries were the most affected by the pandemic, which hindered the market growth. However, due to rising cases of COVID-19, and many countries approved the use of antiviral drugs with high potency molecules. For example, remdesivir has been approved for COVID-19 treatment. The overall high-potency APIs/HPAPI market was adversely affected during the COVID-19 Pandemic.


The report covers key developments in the high potency APIs market. Various companies are focusing on organic growth strategies, such as product launches, product approvals, patents, and events. Inorganic growth strategies such as acquisitions, partnerships, and collaborations have encouraged the expansion of business and the customer base of market players. The market players are anticipated to experience lucrative growth opportunities in the coming years due to the rising demand for high potency APIs ( products.

The report also includes the profiles of key high potency APIs market companies, along with their SWOT analysis and market strategies. In addition, it focuses on leading industry players’ information such as company profiles, components and services offered, financial information for the last three years, and key development in the past five years. The list of a few companies engaged in the high potency APIs ( market is mentioned below:

  •   Pfizer Inc
  •   F Hoffmann La Roche Ltd
  •   Eli Lilly and Company
  •   Bristol Myers Squibb Company
  •   Novartis AG
  •   Sanofi
  •   Merck Sharp and Dohme Corp
  •   Bayer AG
  •   AbbVie
  •   Teva Pharmaceutical Industries Ltd

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Market Research

Get more information on this report :

The List of Companies

  1. Pfizer Inc
  2. F Hoffmann La Roche Ltd
  3. Eli Lilly and Company
  4. Bristol Myers Squibb Company
  5. Novartis AG
  6. Sanofi
  7. Merck Sharp and Dohme Corp
  8. Bayer AG
  9. AbbVie
  10. Teva Pharmaceutical Industries Ltd
  11. Lonza
  12. Boehringer Ingelheim International GmbH
  13. Janssen Pharmaceuticals, Inc
  14. Dr. Reddy's laboratories
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount